Unknown

Dataset Information

0

Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.

ABSTRACT:

SUBMITTER: Holt RIG 

PROVIDER: S-EPMC6330076 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.

Holt Richard I G RIG   Gossage-Worrall Rebecca R   Hind Daniel D   Bradburn Michael J MJ   McCrone Paul P   Morris Tiyi T   Edwardson Charlotte C   Barnard Katharine K   Carey Marian E ME   Davies Melanie J MJ   Dickens Chris M CM   Doherty Yvonne Y   Etherington Angela A   French Paul P   French Paul P   Gaughran Fiona F   Greenwood Kathryn E KE   Kalidindi Sridevi S   Khunti Kamlesh K   Laugharne Richard R   Pendlebury John J   Rathod Shanaya S   Saxon David D   Shiers David D   Siddiqi Najma N   Swaby Elizabeth A EA   Waller Glenn G   Wright Stephen S  

The British journal of psychiatry : the journal of mental science 20180925 2

<h4>Background</h4>Obesity is a major challenge for people with schizophrenia.AimsWe assessed whether STEPWISE, a theory-based, group structured lifestyle education programme could support weight reduction in people with schizophrenia.<h4>Method</h4>In this randomised controlled trial (study registration: ISRCTN19447796), we recruited adults with schizophrenia, schizoaffective disorder or first-episode psychosis from ten mental health organisations in England. Participants were randomly allocate  ...[more]

Similar Datasets

Unknown Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial.
| S-EPMC6868690 | biostudies-literature
Methylation profiling Blood DNA methylation profiles from schizophrenia cases, first episode psychosis patients and controls II
2021-04-07 | GSE152027 | GEO
Unknown Randomised controlled trial of clozapine in resistant schizophrenia and schizoaffective disorder.
| S-EPMC12618736 | biostudies-literature
Unknown Molecular Mechanism Biomarkers Predict Diagnosis in Schizophrenia and Schizoaffective Psychosis, with Implications for Treatment.
| S-EPMC10650772 | biostudies-literature
Unknown Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis.
| S-EPMC7886232 | biostudies-literature
Unknown Association between exposome score for schizophrenia and functioning in first-episode psychosis: results from the Athens first-episode psychosis research study.
| S-EPMC10123830 | biostudies-literature
Unknown Automatic language analysis identifies and predicts schizophrenia in first-episode of psychosis.
| S-EPMC9261086 | biostudies-literature
Unknown Contour integration impairment in schizophrenia and first episode psychosis: state or trait?
| S-EPMC4254521 | biostudies-literature
Unknown Bifactor Modeling of the Positive and Negative Syndrome Scale: Generalized Psychosis Spans Schizoaffective, Bipolar, and Schizophrenia Diagnoses.
| S-EPMC6192503 | biostudies-literature
Unknown Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis.
| S-EPMC6609081 | biostudies-literature